by John Conrad | Sep 29, 2022 | iBIO News
iBIO represents the 88,000 jobs in Illinois’ life sciences sector—and we’ve created a Q&A series with our member companies to spotlight some of these exceptional people and their work. Meet Glover (Très) O. Johnson, vice president of Psychiatric Sales at Lundbeck,...
by John Conrad | Sep 13, 2022 | iBIO News
Over 65 Illinois business leaders signed on to a letter delivered on September 13, 2022 to Illinois Congressional Delegation emphasizing the importance of reauthorizing the SBIR/STTR program. The current legislation is set to expire on September 30, 2022 –...
by John Conrad | Jul 29, 2022 | iBIO News
The Federal SBIR/STTR programs are the largest source of early-stage technology financing in the United States and a critical source of funding for Illinois startup ecosystem. Typically the SBIR/STTR program is renewed every 5 years without issue, except for this...
by John Conrad | Jul 29, 2022 | iBIO News
Dear Senate Majority Leader Schumer, Senate Republican Leader McConnell, House Speaker Pelosi, and House Republican Leader McCarthy: The Council of State Bioscience Associations (CSBA) is an alliance of independent, state and territory based, non-profit trade...
by John Conrad | Jul 1, 2022 | Grants, iBIO News
The National Cancer Institute (NCI) recently released a new funding opportunity for biotech companies and university researchers! The new Small Business Transition Grant funds the translation of technology from university to small business, as well as the transition...
by John Conrad | Jun 27, 2022 | iBIO News
If you haven’t noticed from the litany of television ads, we are a few short days away from the 2022 Illinois primary (June 28). So why does this year seem different? As opposed to other years, Illinois voters will select their party nominees for every statewide...
